Sol-Gel Technologies (SLGL) Total Liabilities (2016 - 2026)
Sol-Gel Technologies' (SLGL) quarterly Total Liabilities came in at $7.1 million in Q1 2026, up 3.67% year-on-year from $6.9 million in Q1 2025, and up 0.53% on a QoQ basis from $7.1 million in Q4 2025.
Sol-Gel Technologies (SLGL) Total Liabilities (2016 - 2026) Analysis & Trends
Sol-Gel Technologies (SLGL) has 11 years of Total Liabilities data on file, last reported at $7.1 million in Q1 2026.
- On a quarterly basis, Total Liabilities rose 3.67% year-over-year to $7.1 million in Q1 2026; TTM through Mar 2026 was $7.1 million, a 3.67% increase from a year earlier, with the FY2025 full-year figure at $7.1 million, up 1.57% from the prior year.
- Total Liabilities for Q1 2026 stood at $7.1 million, up from $7.1 million in the prior quarter.
- Over the last five years, Total Liabilities for SLGL reached as high as $8.6 million in Q3 2025 and fell as low as $3.8 million in Q3 2022.
- Historically, Total Liabilities has averaged $6.5 million across 5 years, with a median of $6.9 million in 2025.
- Across the five-year window, Total Liabilities slumped 67.52% in 2022 and surged 76.61% in 2023, its largest moves.
- Year by year, Total Liabilities stood at $4.4 million in 2022, then jumped by 50.46% to $6.6 million in 2023, then grew by 5.31% to $7.0 million in 2024, then grew by 1.57% to $7.1 million in 2025, then rose by 0.53% to $7.1 million in 2026.
- Per Business Quant data, the three most recent Total Liabilities figures were $7.1 million in Q1 2026, $7.1 million in Q4 2025, and $8.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 60.46 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 177.22 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 3.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 7.33 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 7.12 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 9.45 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 15.48 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.62 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 753.82 Mn |
| 10 | Sol-Gel Technologies | 227.58 Mn | 217.44 Mn | - | 7.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.14 Mn |
| Dec 31, 2025 | 7.11 Mn |
| Sep 30, 2025 | 8.56 Mn |
| Jun 30, 2025 | 7.43 Mn |
| Mar 31, 2025 | 6.89 Mn |
| Dec 31, 2024 | 7.00 Mn |
| Sep 30, 2024 | 8.28 Mn |
| Jun 30, 2024 | 7.10 Mn |
| Mar 31, 2024 | 7.26 Mn |
| Dec 31, 2023 | 6.64 Mn |
| Sep 30, 2023 | 6.74 Mn |
| Jun 30, 2023 | 6.81 Mn |
| Mar 31, 2023 | 4.98 Mn |
| Dec 31, 2022 | 4.42 Mn |
| Sep 30, 2022 | 3.81 Mn |
| Jun 30, 2022 | 4.63 Mn |
| Mar 31, 2022 | 5.93 Mn |
| Dec 31, 2021 | 13.60 Mn |
| Sep 30, 2021 | 11.38 Mn |
| Jun 30, 2021 | 7.16 Mn |